Advertisement

FXIII deficiency due to base exchange Thr 449 (ACT) → Ile (ATT) in exon 11 of the factor 13A gene

Journal:Hämostaseologie
ISSN:0720-9355
Issue:Issues of 2010 (Vol. 30): Issue 3 2010 (123-178)
Pages:162-164

FXIII deficiency due to base exchange Thr 449 (ACT) → Ile (ATT) in exon 11 of the factor 13A gene

A cause of bleeding?

B. Maak (1), L. Kochhan (2), P. Heuchel (3), J. Jenderny (2)

(1) Praxis für Kinder- und Jugendmedizin, MVZ der Thüringen-Kliniken Saalfeld-Rudolstadt; (2) Abteilung Humangenetik, Labor Lademannbogen, Hamburg; (3) Labor Dr. Heuchel, Saalfeld, Germany

Summary

A 17-year old man was sent to us for coagulation testing because he suffered from acute bleeding which started immediately after making an incision in the skin for a urological surgery. The patient had a history of mild bleeding symptoms (nose bleeds during the childhood, gingival bleeds). Results of laboratory investigations: Blood group 0, closure times (PFA 100):132 s (ADP/collagen) and 300 s (epinephrine/collagen), VWF antigen 57%, VWF activity 50%, factor VIII activity 66%, factor XIII activity 59%. The results were confirmed by further investigations. Additionally, two relevant genetic findings were obtained: first a heterozygous base exchange in exon 11 of the factor 13A gene -Thr 449 (ACT)>Ile (ATT)-, not described before the completion of the study, and second the homozygous state of the 807 C-allele within the integrin α2 gene. The patient inherited the base exchange in the factor 13A gene from his mother. Homozygosity of the 807 C allele in the integrin α2 gene is associated with a very low expression of the platelet collagen receptor. Individuals with low VWF due to blood group 0 and low platelet collagen receptor density often exhibit a bleeding tendency, e.g. bleedings from mucosal membranes or menorrhagia in females. Conclusion: In our opinion the light factor XIII deficiency in our patient is coincidental and not the sole cause of bleeding.

Keywords

bleeding tendency, Factor XIII deficiency, low von Willebrand factor

You may also be interested in...

1.

K. Borucki1, G. Töpfer2, K.-J. Hartung1, G. Lutze1

Hämostaseologie 2007 27 3: 188-190

2.

A. Kappel (1), S. Stephan (1), C. Duwe (1), L. Pechmann (1), H. Althaus (1), M. Ehm (1), B. Fischer (1), M. Hahn (1), H. Schwarz (1), F. Vitzthum (1)

Hämostaseologie 2011 31 2: 105-109

http://dx.doi.org/10.5482/ha-1150